Dr. Dana Lerman, CEO of Skylight Psychedelics, discusses the democratization of psychedelic therapy and the importance of proper training and support for therapists. Skylight Psychedelics offers affordable training programs for therapists and aims to provide access to medication for patients. Dr. Lerman emphasizes the need for a safe and supported environment for psychedelic experiences, highlighting the risks of unsupervised ketamine use at home. Skylight Psychedelics also focuses on incorporating lesser-known medicines, such as ayahuasca and iboga, into their training programs. Dr. Lerman expresses her support for upcoming legislation that aims to decriminalize and legalize psychedelic therapy, emphasizing the urgent need for widespread access to these treatments.
Cannabis Business Interviews: Is Europe the Future of Cannabis? Steven Murphy Weighs In
This engaging discussion with Richard Zwicky and Steven Murphy, CEO of Prohibition Partners, explores the dynamic world of the global cannabis industry, offering valuable insights into current trends, regulatory challenges, and emerging opportunities. Steven and Read more…